(Isstories Editorial):- Mumbai, Maharashtra Feb 13, 2024 (Issuewire.com) – Sonablate, a pioneering medical technology company, recently unveiled its latest innovation at the Kokilaben Dhirubhai Ambani Hospital (Mumbai) and the Rajiv Gandhi Cancer Institute and Research Centre (Delhi): Sonablate HIFU (High-Intensity Focused Ultrasound) technology. This groundbreaking advancement is a minimally invasive robotic device offering precise and focused ablative energy to patients with prostate conditions. NovoMed Incorporation Pvt Ltd is the authorised distributor of the Sonablate HIFU Robotic Device in India.
The key benefit of the Sonablate HIFU Technology is the fact, that it is a customizable procedure targeting only the affected prostate issue, thereby reducing risk of collateral damage to surrounding healthy tissues. Further, it is also a minimally invasive, radiation-free, bloodless ablation with much shorter recovery periods.
Speaking on the occasion Dr Yuvaraja, Head- Robotic Surgery, and Consultant-Surgical Oncology (URO-ONCOLOGY), at Kokilaben Dhirubhai Ambani Hospital, opined, “I have recently started using this technology and have successfully completed five HIFU procedures for prostate cancer in this short time. My experience has been excellent. There are many advantages of this procedure for patients and the surgical team as well. Patients wake up from anaesthesia without any pain from the surgery. They resume ambulation on the same day, just with a urinary catheter. They can be discharged the next day of surgery and the catheter can be removed at home after three days. Therefore, these patients have very quick recovery as compared to those who undergo conventional surgery. Our patients tolerated this procedure better than prostate biopsies. Out of all these five cases, only one patient had complaints of mild urgency during urination. Intra-operatively also the machine was very easy to use and user-friendly. Overall, I had a very good satisfying experience.”
More on Isstories:
- CM Club Hits the Beach in Style with Its New Golden Beach Collection: Luxe Tops Proudly Made in the USA
- Antoinette “Red Lotus Chic”Apolon, Recognized by BestAgents.us as a 2024 Top Agent
- Toronto’s Waterproofing Season: Protect Your Basement This Summer
- Presentria is named as one of Canada’s Top 10 Student Engagement Solutions Providers for 2024
- Sat Nijjer, CEO of Fortel Group Expands Finance Team with Two Key Midlands HQ Appointments
Rajesh Kumar Sharma ( Name Changed to Protect Identity), a patient of Dr Yuvaraja, underwent the procedure in October and was discharged the very next day. Sunil Kumar Verma stated, “Needless to say that the procedure, the way I see it, has been good. The hospitalisation period was short. I felt absolutely normal within two days and could even travel abroad for a vacation within two weeks. Most importantly, I am not on any additional medicines now, and leading an active healthy life.”
Dr. Sudhir Rawal, Medical Director and Chief of GenitoUro – Oncology Services, Rajiv Gandhi Cancer Institute and Research Centre, opined, “Our Institute has been using this machine since February 2023 and till now it has been working smoothly. It is a user-friendly device which requires proper training prior to the onset of the program. This procedure gives minimal discomfort and the least side effects to the patient with adequate treatment for the disease. Intraoperative and postoperative complications of Radical prostatectomy (RALP) like pain, erectile dysfunction, urinary incontinence etc. are avoided. Also, the side effects of radiation like GI toxicity, hematuria etc. are avoided. The patient also has an option of surgical, or radiation treatment if there is recurrence.”
Harinder Singh Ratra, an eighty year old patient of Dr Sudhir Rawal, from Punjab, expressed his deep gratitude and stated,” The procedure was performed on me in the month of June. It was done very efficiently and professionally and I recovered within a week. On a follow up visit in the month of September, the MRI scan showed no sign of disease. Dr Sudhir Rawal and his team of dedicated professionals have given me a new lease on life.”
Jay Mehta, Director- Sales, NovoMed Incorporation Pvt Ltd, aptly sums it up by asserting, “We are thrilled to introduce Sonablate HIFU Technology, a game changer in the field of prostate care. This significant advancement in healthcare technology will ensure a highly improved quality of life for patients with prostate conditions.
This article was originally published by IssueWire. Read the original article here.
